Cargando…

Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis

OBJECTIVE: To assess whether patients with aortic valve stenosis (AS) with elevated lipoprotein(a) (Lp(a)) are characterised by increased valvular calcification activity compared with those with low Lp(a). METHODS: We performed (18)F-sodium fluoride ((18)F-NaF) positron emission tomography/CT in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaiser, Yannick, Nurmohamed, Nick S, Kroon, Jeffrey, Verberne, Hein J, Tzolos, Evangelos, Dweck, Marc R, Somsen, Aernout G, Arsenault, Benoit J, Stroes, Erik S G, Zheng, Kang H, Boekholdt, S Matthijs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666821/
https://www.ncbi.nlm.nih.gov/pubmed/34593533
http://dx.doi.org/10.1136/heartjnl-2021-319804
_version_ 1784614276625858560
author Kaiser, Yannick
Nurmohamed, Nick S
Kroon, Jeffrey
Verberne, Hein J
Tzolos, Evangelos
Dweck, Marc R
Somsen, Aernout G
Arsenault, Benoit J
Stroes, Erik S G
Zheng, Kang H
Boekholdt, S Matthijs
author_facet Kaiser, Yannick
Nurmohamed, Nick S
Kroon, Jeffrey
Verberne, Hein J
Tzolos, Evangelos
Dweck, Marc R
Somsen, Aernout G
Arsenault, Benoit J
Stroes, Erik S G
Zheng, Kang H
Boekholdt, S Matthijs
author_sort Kaiser, Yannick
collection PubMed
description OBJECTIVE: To assess whether patients with aortic valve stenosis (AS) with elevated lipoprotein(a) (Lp(a)) are characterised by increased valvular calcification activity compared with those with low Lp(a). METHODS: We performed (18)F-sodium fluoride ((18)F-NaF) positron emission tomography/CT in patients with mild to moderate AS (peak aortic jet velocity between 2 and 4 m/s) and high versus low Lp(a) (>50 mg/dL vs <50 mg/dL, respectively). Subjects were matched according to age, gender, peak aortic jet velocity and valve morphology. We used a target to background ratio with the most diseased segment approach to compare (18)F-NaF uptake. RESULTS: 52 individuals (26 matched pairs) were included in the analysis. The mean age was 66.4±5.5 years, 44 (84.6%) were men, and the mean aortic valve velocity was 2.80±0.49 m/s. The median Lp(a) was 79 (64–117) mg/dL and 7 (5–11) mg/dL in the high and low Lp(a) groups, respectively. Systolic blood pressure and low-density-lipoprotein cholesterol (corrected for Lp(a)) were significantly higher in the low Lp(a) group (141±12 mm Hg vs 128±12 mm Hg, 2.5±1.1 mmol/L vs 1.9±0.8 mmol/L). We found no difference in valvular (18)F-NaF uptake between the high and low Lp(a) groups (3.02±1.26 vs 3.05±0.96, p=0.902). Linear regression analysis showed valvular calcium score to be the only significant determinant of valvular (18)F-NaF uptake (β=0.63; 95% CI 0.38 to 0.88 per 1000 Agatston unit increase, p<0.001). Lp(a) was not associated with (18)F-NaF uptake (β=0.17; 95% CI −0.44 to 0.88, p=0.305 for the high Lp(a) group). CONCLUSION: Among patients with mild to moderate AS, calcification activity is predominantly determined by established calcium burden. The results do not support our hypothesis that Lp(a) is associated with valvular (18)F-NaF uptake.
format Online
Article
Text
id pubmed-8666821
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-86668212021-12-28 Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis Kaiser, Yannick Nurmohamed, Nick S Kroon, Jeffrey Verberne, Hein J Tzolos, Evangelos Dweck, Marc R Somsen, Aernout G Arsenault, Benoit J Stroes, Erik S G Zheng, Kang H Boekholdt, S Matthijs Heart Valvular Heart Disease OBJECTIVE: To assess whether patients with aortic valve stenosis (AS) with elevated lipoprotein(a) (Lp(a)) are characterised by increased valvular calcification activity compared with those with low Lp(a). METHODS: We performed (18)F-sodium fluoride ((18)F-NaF) positron emission tomography/CT in patients with mild to moderate AS (peak aortic jet velocity between 2 and 4 m/s) and high versus low Lp(a) (>50 mg/dL vs <50 mg/dL, respectively). Subjects were matched according to age, gender, peak aortic jet velocity and valve morphology. We used a target to background ratio with the most diseased segment approach to compare (18)F-NaF uptake. RESULTS: 52 individuals (26 matched pairs) were included in the analysis. The mean age was 66.4±5.5 years, 44 (84.6%) were men, and the mean aortic valve velocity was 2.80±0.49 m/s. The median Lp(a) was 79 (64–117) mg/dL and 7 (5–11) mg/dL in the high and low Lp(a) groups, respectively. Systolic blood pressure and low-density-lipoprotein cholesterol (corrected for Lp(a)) were significantly higher in the low Lp(a) group (141±12 mm Hg vs 128±12 mm Hg, 2.5±1.1 mmol/L vs 1.9±0.8 mmol/L). We found no difference in valvular (18)F-NaF uptake between the high and low Lp(a) groups (3.02±1.26 vs 3.05±0.96, p=0.902). Linear regression analysis showed valvular calcium score to be the only significant determinant of valvular (18)F-NaF uptake (β=0.63; 95% CI 0.38 to 0.88 per 1000 Agatston unit increase, p<0.001). Lp(a) was not associated with (18)F-NaF uptake (β=0.17; 95% CI −0.44 to 0.88, p=0.305 for the high Lp(a) group). CONCLUSION: Among patients with mild to moderate AS, calcification activity is predominantly determined by established calcium burden. The results do not support our hypothesis that Lp(a) is associated with valvular (18)F-NaF uptake. BMJ Publishing Group 2022-01 2021-09-30 /pmc/articles/PMC8666821/ /pubmed/34593533 http://dx.doi.org/10.1136/heartjnl-2021-319804 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Valvular Heart Disease
Kaiser, Yannick
Nurmohamed, Nick S
Kroon, Jeffrey
Verberne, Hein J
Tzolos, Evangelos
Dweck, Marc R
Somsen, Aernout G
Arsenault, Benoit J
Stroes, Erik S G
Zheng, Kang H
Boekholdt, S Matthijs
Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis
title Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis
title_full Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis
title_fullStr Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis
title_full_unstemmed Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis
title_short Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis
title_sort lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis
topic Valvular Heart Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666821/
https://www.ncbi.nlm.nih.gov/pubmed/34593533
http://dx.doi.org/10.1136/heartjnl-2021-319804
work_keys_str_mv AT kaiseryannick lipoproteinahasnomajorimpactoncalcificationactivityinpatientswithmildtomoderateaorticvalvestenosis
AT nurmohamednicks lipoproteinahasnomajorimpactoncalcificationactivityinpatientswithmildtomoderateaorticvalvestenosis
AT kroonjeffrey lipoproteinahasnomajorimpactoncalcificationactivityinpatientswithmildtomoderateaorticvalvestenosis
AT verberneheinj lipoproteinahasnomajorimpactoncalcificationactivityinpatientswithmildtomoderateaorticvalvestenosis
AT tzolosevangelos lipoproteinahasnomajorimpactoncalcificationactivityinpatientswithmildtomoderateaorticvalvestenosis
AT dweckmarcr lipoproteinahasnomajorimpactoncalcificationactivityinpatientswithmildtomoderateaorticvalvestenosis
AT somsenaernoutg lipoproteinahasnomajorimpactoncalcificationactivityinpatientswithmildtomoderateaorticvalvestenosis
AT arsenaultbenoitj lipoproteinahasnomajorimpactoncalcificationactivityinpatientswithmildtomoderateaorticvalvestenosis
AT stroeseriksg lipoproteinahasnomajorimpactoncalcificationactivityinpatientswithmildtomoderateaorticvalvestenosis
AT zhengkangh lipoproteinahasnomajorimpactoncalcificationactivityinpatientswithmildtomoderateaorticvalvestenosis
AT boekholdtsmatthijs lipoproteinahasnomajorimpactoncalcificationactivityinpatientswithmildtomoderateaorticvalvestenosis